Yes but that will be the BP offer for a product end of Ph2. They usually make their move end of Ph2 as that's when efficacy is seen in clinical trial but CF33 has already seen very positive efficacy at the start of Ph1 which is very rare so I see them making their move more toward the middle of Ph2 or even the start of Ph2.
Media Thread, page-12300
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.002(3.45%) |
Mkt cap ! $409.9M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.5¢ | $666.4K | 11.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 732501 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 802115 | 16 |
View Market Depth
| Last trade - 13.16pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.002 ( 0.18 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.7¢ | 5.5¢ | 3543295 | ||
| Last updated 14.07pm 17/06/2024 ? | |||||
| IMU (ASX) Chart |
